This publications portal is a repository of all IOM migration health publications from 2006 to present where IOM was a primary contributor.
Publications include peer-reviewed scientific papers, technical reports, training guides/manuals, policy briefs/discussion papers, factsheets, newsletters, research reviews, conference and poster presentations. These are categorized by topic, author, country/region covered as well as by year, language, and type of publication. The map reflects the countries covered by the publications.
To browse or search: simply use the filter options on the left-hand side. Alternatively, you can enter keyword/s in the search box. Selecting a specific publication will lead to a ‘download’ link or link to the website where the document is housed. Here is the step-by-step guide for your reference.
Author/s: Yasmine Zaki Abdelaziz, Gemma Arthurson, Haley West, Antonio Torres
The humanitarian community has had to learn about COVID-19 while responding to this new disease. From the start it was known that basic hygiene practices, such as proper handwashing, could help prevent its transmission. However, many displacement settings do not have the required facilities for implementing household and community-level Infection Prevention and Control (IPC) measures. They may also have weak governance systems for managing and maintaining water, sanitation, and hygiene (WASH…Read more
100% TB treatment success is possible: Championing the International Organization for Migration (IOM) tuberculosis DOT and patient-centered care among refugees and other migrants undergoing pre-immigration medical examinations
Author/s: Kipsang Melly, Dhillon Nyachieco, and Miriti Damaris
A poster abstract prepared by IOM Kenya for the North American Refugee Health Conference in Oregon, USA, 7-9 June 2018.
This poster won the “Best Scientific Poster, 2018 North American Refugee Health Conference."
The study reviewed the characteristics of patients amd treatment outcome at IOM's Kenya TB DOT clinics from 2010 to 2016, including detection rates, diagnostic sputum status, drug susceptibiity test patterns and success rates.
Provision of comprehensive HIV/AIDS and TB Services in Protection of Civilian (PoC) Sites in South Sudan
Author/s: Beldina Gikundi, Marian Solangon, Kelsi Kriitmaa, Phineas Jasi, Forward Makonese, Saul Akandwanaho, Benson Otieno, and Salma Taher
A poster abstract prepared by IOM South Sudan for the 22nd International AIDS Conference (AIDS 2018) in Amsterdam, 23-27 July 2018.
Author/s: Jacob Creswell, Andrew Collins, Emmanuel Andre, Mark Micek, Ahmed Bedru, E Jane Carter, Rajendra-Prasa Yadav, Andrei Mosneaga, Bishwa Raj, Sayera Banu, Miranda Brouwer, Lucie Blok, Suvanand Sahu, Lucica Ditiu
Background: The Xpert MTB/RIF assay has garnered significant interest as a sensitive and rapid diagnostic tool to improve detection of sensitive and drug resistant tuberculosis. However, most existing literature has described the performance of MTB/RIF testing only in study conditions; little information is available on its use in routine case finding. TB REACH is a multi-country initiative focusing on innovative ways to improve case notification.
Author/s: IOM Africa and Middle East
Migration Health is a regional newsletter highlighting how IOM and partners are making a difference to the lives of migrants and mobile populations across Africa and the Middle East. Packed with news features, interviews, photo galleries and IOM’s latest research, the newsletter underpins the Migration Health Division's core mandate to promote and deliver evidence-informed health policies and programmes which are beneficial, accessible, and equitable for…
Presumptive Treatment to Reduce Imported Malaria among Refugees from East Africa Resettling in the United States
Author/s: Christina Phares, Bryan Kapella, Annelise Doney, Paul Arguin, Michael Green, Leul Mekonnen, Aleksander Galev, Michelle Weinberg, William Stauffer
Abstract: During May 4, 2007–February 29, 2008, the United States resettled 6,159 refugees from Tanzania. Refugees received pre-departure antimalarial treatment with sulfadoxine-pyrimethamine (SP), partially supervised (three/six doses) artemether-lumefantrine (AL), or fully supervised AL. Thirty-nine malaria cases were detected. Disease incidence was 15.5/1,000 in the SP group and 3.2/1,000 in the partially supervised AL group (relative change = –79%, 95% confidence…Read more